Next Article in Journal
Finding Biomarkers in Antioxidant Molecular Mechanisms for Ensuring Food Safety of Bivalves Threatened by Marine Pollution
Next Article in Special Issue
Can Photobiomodulation Therapy (PBMT) Minimize Exercise-Induced Oxidative Stress? A Systematic Review and Meta-Analysis
Previous Article in Journal
Prenatal Fine Particulate Matter, Maternal Micronutrient Antioxidant Intake, and Early Childhood Repeated Wheeze: Effect Modification by Race/Ethnicity and Sex
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Antioxidants
Volume 11
Issue 2
10.3390/antiox11020368
antioxidants-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Communication

OxInflammation at High Altitudes: A Proof of Concept from the Himalayas

by
Simona Mrakic-Sposta
1,†,
Denise Biagini
2,*,†,
Danilo Bondi
3,
Tiziana Pietrangelo
3,
Alessandra Vezzoli
1,
Tommaso Lomonaco
2,
Fabio Di Francesco
2 and
Vittore Verratti
4
1
Institute of Clinical Physiology, National Research Council (IFC-CNR), 20162 Milan, Italy
2
Department of Chemistry and Industrial Chemistry, University of Pisa, 56126 Pisa, Italy
3
Department of Neuroscience, Imaging and Clinical Sciences, University “G. d’Annunzio” of Chieti, Pescara, 66100 Chieti, Italy
4
Department of Psychological, Health and Territorial Sciences, University “G. d’Annunzio” of Chieti, Pescara, 66100 Chieti, Italy
*
Author to whom correspondence should be addressed.
†
These authors contributed equally.
Antioxidants 2022, 11(2), 368; https://0-doi-org.brum.beds.ac.uk/10.3390/antiox11020368
Submission received: 21 January 2022 / Revised: 7 February 2022 / Accepted: 10 February 2022 / Published: 11 February 2022
(This article belongs to the Special Issue Antioxidants in Skeletal Muscle Physiological and Pathological Conditions)
Browse Figures
Versions Notes

Abstract

:
High-altitude locations are fascinating for investigating biological and physiological responses in humans. In this work, we studied the high-altitude response in the plasma and urine of six healthy adult trekkers, who participated in a trek in Nepal that covered 300 km in 19 days along a route in the Kanchenjunga Mountain and up to a maximum altitude of 5140 m. Post-trek results showed an unbalance in redox status, with an upregulation of ROS (+19%), NOx (+28%), neopterin (+50%), and pro-inflammatory prostanoids, such as PGE2 (+120%) and 15-deoxy-delta12,14-PGJ2 (+233%). The isoprostane 15-F2t-IsoP was associated with low levels of TAC (−18%), amino-thiols, omega-3 PUFAs, and anti-inflammatory CYP450 EPA-derived mediators, such as DiHETEs. The deterioration of antioxidant systems paves the way to the overload of redox and inflammative markers, as triggered by the combined physical and hypoxic stressors. Our data underline the link between oxidative stress and inflammation, which is related to the concept of OxInflammation into the altitude hypoxia fashion.

1. Introduction

High altitude exposure triggers marked physiological responses and adaptations [1]. For this reason, challenges to human homeostasis by such environmental stressors [2] provide an intriguing ecological model to reproduce physiological and pathophysiological conditions that share hypoxemia as the common denominator. In fact, altitude travel has increased massively in the last few decades, and the combination of physical activity and altitude hypoxia, as in high-altitude treks, enables medical and physiological responses to be investigated in the field [3,4].
Hypoxia-induced inflammation impacts on the immune function and causes chronic disease and high-altitude illnesses [5]. In the same vein, redox homeostasis has been widely studied as disrupted by hypoxia conditioning [6]. Hypobaric hypoxia negatively affects redox homeostasis, leading to the generation of reactive species and consequently to damage of cellular compartments (i.e., lipids and proteins) and the degeneration of antioxidant systems [7,8]. On the other hand, ascent to high altitudes can lead to an excessive inflammatory response [7,9,10] with increased levels of proinflammatory cytokines [7,9,10]. The reciprocal interplay between oxidative stress and inflammation has been termed as OxInflammation, and it is a source of biomarkers for monitoring the pre-pathological conditions triggered by environmental stressors [11].
Oxylipins are well-known markers of oxidative damage and inflammation [12] as well as powerful lipid mediators generated from both omega-3 and omega-6 polyunsaturated fatty acids (PUFAs) [13]. PUFAs act as precursors of pro-inflammatory, anti-inflammatory, and specialized pro-resolving lipid mediators (SPMs) through enzymatic oxidation reactions [14].
Pro-inflammatory mediators released at the very beginning of inflammation foster the appearance of its classic signs, whereas the switch to lipoxygenase-derived anti-inflammatory and pro-resolving mediators leads to a natural resolution of inflammation [15]. PUFAs can also undergo free radical-mediated oxidation, thus generating well-established markers of oxidative stress such as isoprostanes (e.g., 15-F2t-IsoP, 15-E2t-IsoP) [16]. High levels of F2-isoprostane have been observed after both acute and chronic high-altitude exposure and were correlated with increased plasma levels of total glutathione [17]. High-altitude research expeditions up to 4000–5000 m have induced a temporary increase in F2-isoprostane concentration compared with that observed at sea levels [18,19], thus suggesting the combined effect of altitude exposure and exercise on cellular (even nervous system-related) oxidative damage [20].
It is thus clear that high-altitude treks increase oxidative stress and trigger a pronounced inflammatory response. However, these phenomena and their interaction are currently still being characterized in depth. Our field study on high-altitude trekkers in the Himalayas explores the new concept of OxInflammation. We propose the comprehensive monitoring of the redox status and antioxidant capacity together with the measurement of a wide panel of oxylipins for a full characterization of oxidative damage and immune-inflammatory response.

2. Materials and Methods

This work is part of the “Kanchenjunga Exploration & Physiology” research project, which is a subset of the project “environmentally-modulated metabolic adaptation to hypoxia in altitude natives and sea-level dwellers: from integrative to molecular (proteomics, epigenetics, and ROS) level”. The project was approved by the Ethical Review Board of the Nepal Health Research Council (NHRC, ref. no. 458). All the study procedures complied with the ethical standards of the Helsinki declaration, and written informed consent was obtained before sample and data collection.
The group of trekkers was composed by one female and five males, aged 40 ± 20 years, with a BMI of 26 ± 3 kg/m2. Participants completed a trek of 300 km in 19 days along a demanding route in the Kanchenjunga Mountain (Himalayas, Nepal), up to a maximum altitude of 5140 m (North Base Camp).
Blood was drawn from the antecubital vein two weeks before the start of the trip and the day after the end of the Himalayan trek. The first blood sample was collected in Vacutainer® tubes and immediately centrifuged (3000 rpm × 10 min). The second sample was stored at −5 °C during transport to Italy for later analyses. For the oxylipin analyses, the antioxidant butylhydroxytoluene (BHT, 15 mg/mL in methanol) was added (1:100, BHT:sample) before storage to preserve PUFAs from in vitro lipid peroxidation [21]. First-void urinary samples were immediately frozen at −20 °C and stored until analysis. Daily food, water, MUFA, and PUFA intake were self-recorded by the subjects, on three non-consecutive days during the trek [22].
An X band electron paramagnetic resonance spectroscopy (9.3 GHz) (E-Scan-Bruker BioSpin, GmbH, Billerica, MA, USA) was used to assess total ROS production and total antioxidant capacity (TAC) at pre- and post-high-altitude trek.
CMH (1-hydroxy-3-methoxycarbonyl-2,2,5,5-tetramethylpyrrolidine) spin probe was used for ROS determination. 50 μL of sample were treated with CMH solution (1:1). 50 μL of the obtained solution were put in a glass EPR capillary tube (Noxygen Science Transfer & Diagnostics, Elzach, Germany) that was placed inside the cavity of the E-scan spectrometer for data acquisition with the following parameters of acquisition: microwave frequency 9.652 GHz; modulation frequency 86 kHz; modulation amplitude 2.28 G; sweep width 60 G, microwave power 21.90 mW, number of scans 10; and receiver gain 3.17⋅101. A stable radical CP · (3-carboxy2,2,5,5-tetramethyl-1-pyrrolidinyloxy) was used as an external reference to convert ROS determinations in absolute quantitative values (μmol•min−1), as previously indicated [7,8,23].
TAC was measured using 1,1-diphenyl-2-picrylhydrazyl (DPPH•), a free radical compound soluble and stable in ethanol. 5 μL of plasma were added to 45 μL of buffer solution (5 mM potassium phosphate, pH 7.4 containing 0.9% sodium chloride) then reaction was initiated by the addition of 50 μL of DPPH• as a source of free radicals, as previously indicated [24,25,26]. Reaction mixture was incubated for 30 min at dark room temperature (for the photochemical effect on DPPH) and then 50 μL of the obtained solution was put in the glass EPR capillary tube. The calculated antioxidant capacity was expressed in terms of Trolox equivalent antioxidant capacity (TAC, mM).
All samples were stabilized at 37 °C with “Bio III” unit (Bio III—Noxigen Science Transfer & Diagnostics GmbH, Germany), interfaced to the spectrometer. Spectra were recorded and analyzed using Win EPR software (2.11 version) standardly supplied by Bruker.
Assessment methods have been previously described [23,26,27]. Total aminothiols (Cys: cysteine; CysGly: cysteinylglycine; Hcy: homocysteine; and GSH: glutathione) were measured by high-performance liquid chromatography (HPLC) according to previously validated methods [28,29]. NO metabolites (NOx) concentrations were determined in urine via a colorimetric method based on the Griess reaction, using a commercial kit (Cayman Chemical, Ann Arbor, MI, USA) as previously described [26,30]. Urinary creatinine, neopterin, and uric acid concentrations were measured by the HPLC method as previously described [7].
The MS-based targeted profiling of 25 plasma oxylipins—i.e., isoprostanes (15-F2t-IsoP and 15-E2t-IsoP), prostanoids (TXB2, PGE2 and 15-deoxy-delta12,14-PGJ2), hydroxy- and epoxy-fatty acids (8,9-EET, 11,12-EET, 14,15-EET, 13-HODE, 5-HETE, 12-HETE, 15-HETE, 20-HETE, 8,9-DiHETE, 11,12-DiHETE, 14,15-DiHETE), and of omega-3/omega-6 PUFAs (AdA, EPA, alpha-LA, la, DHA, DPA, AA) was performed using micro-extraction by packed sorbent (MEPS) liquid chromatography tandem mass spectrometry (MEPS-LC-MS/MS) platform [31,32]. Briefly, plasma proteins were precipitated by the sequential addition of salts (i.e., 250 µL of CuSO4·5 H2O 10% w/v and 250 µL of Na2WO4·2 H2O 12% w/v) and acetonitrile (500 µL) to the plasma sample (500 µL). The supernatant was then diluted (1:6 v/v) with water and subjected to MEPS extraction. The methanolic extract was directly injected into the UHPLC-MS/MS system and oxylipins were analyzed as described elsewhere [33].
Statistical analyses were carried out with the open-source R-based software Jamovi v. 1.6.18.0. Data were initially checked for normality with the Shapiro–Wilk test, then LEU-B4, 8,9-DiHETE, 8,9-EET, DPA and NOx data were log-transformed, whereas uric acid data were loglog-transformed; PGD2 was removed from the analysis due to missing data. After a Kolmogorov–Smirnov check for normality, a series of paired sample t-tests were carried out. The effect size (Cohen’s d) was adjusted to the unbiased value for low sample size as dunb = d[1-3/(4df-1)], then graphs were created using Prism v. 9.2.0 (GraphPad Software, San Diego, CA, USA).
Data were also analyzed by a multivariate exploratory method (principal component analysis, PCA [34]) using MetaboAnalyst v. 5.0 (Wishart Research group, The Metabolomics Innovation Centre (TMIC), University of Alberta, Canada) [35,36]. The dataset included the plasma levels of 23 oxylipins and the 11 markers of both the redox status and the antioxidant capacity. Two out of 25 oxylipins (i.e., 15-E2t-IsoP and PGD2) were excluded from the dataset as the concentrations were below the limit of quantification for more than 50% of samples. The original data were pre-processed (data integrity and missing value check) and normalized (i.e., square root transformation and data autoscaling) prior to the multivariate analysis [37].

3. Results

The average daily intake of participants, estimated from food diaries loaded into an ad-hoc web database [22], included 39 ± 9 g (13 ± 2% of the total energy intake) of PUFAs among other nutrients and 3000 ± 500 g of water. The trekkers suffered the combined stress of physical exercise and hypoxia, as elsewhere reported with a suppression of the hypothalamus-pituitary gonadal axis and altered thyroid metabolic function [38], a weight loss and a reduction in total body water [22], while the mood disturbance scores were lower at high altitude [39].
Significant increases post-trek of ROS production rate (0.18 ± 0.01 vs. 0.22 ± 0.01 μmol min−1) (Figure 1a), NOx (300 ± 200 vs. 400 ± 200 μM) (Figure 1c), total Hcy and GSH (5.3 ± 0.9 vs. 7 ± 2; 1100.0 ± 200 vs. 2000 ± 200 μmol L−1 respectively) were detected (Figure 1g,h). Conversely, TAC (3.5 ± 0.2 vs. 2.9 ± 0.2 mM), and total Cys and CysGly (58 ± 8 vs. 22 ± 8; 80 ± 10 vs. 40 ± 10 μmol L−1 respectively) significantly decreased at post. Changes in uric acid levels were far from significance (0.4 ± 0.4 vs. 0.4 ± 0.5 μmol L−1, respectively). While at post, a significant increase in neopterin was observed (100 ± 30 vs. 160 ± 20 μmol mol−1 creatinine, Figure 1d). The overall statistical results are reported in Table 1.
The PCA also highlighted a clear separation among samples collected pre- and post- high-altitude trek. Figure 2 shows the score (a) and loading plots (b) of PCA for the pre-processed data. The two lowest-order principal components accounted for a total explained variance of about 56%. PC1 scores provided the main contribution to the separation between the two sample classes, with pre-trek samples (red circle) showing negative score values, whereas the post-trek (green circle) showed positive scores (Figure 2a). Post-trek samples were mostly characterized by an upregulation of ROS, NOx, total GSH, urinary neopterin, pro-inflammatory prostanoids (e.g., PGE2 and 15-deoxy-delta12,14-PGJ2), and isoprostane 15-F2t-IsoP (Figure 2b). These samples were associated with low levels of TAC, total Gly and CysGly, omega-3 PUFAs (e.g., DHA, EPA, DPA) and, to a lesser extent, anti-inflammatory CYP450 EPA-derived mediators such as DiHETEs (Figure 2b). Oxylipin mean concentration levels pre- and post-trek are reported in Table 2.

4. Discussion

The combined effect of high altitude and physical exercise on oxidative stress has long remained unknown [40], and the limited knowledge available derives from a small number of recent field and lab simulation studies [41]. Omics sciences are however now helping to shed new light on the complex metabolic rearrangement caused by altitude hypoxia [42,43]. Muscles working under hypoxic environments are overstressed, and the deterioration of antioxidant systems leads to the loss of protective molecular processes [44]. Indeed, altered redox homeostasis as compromised by hypobaric hypoxia determines an impairment of muscle performance and paves the way to skeletal muscle atrophy [45].
Here, we combined a high-throughput analytical platform for the targeted metabolomic profiling of oxylipins to the measurement of ROS and antioxidants for a comprehensive characterization of high-altitude induced redox homeostasis disruption and inflammatory response. In line with the literature [7,8,10,46], we found that high altitude increases the production of ROS and decreases the antioxidant capacity, thus modifying the weighing pan, as suggested by the increase in ROS, NOx, oxidative damage biomarkers (i.e., 15-F2t-IsoP), and unbalanced redox status (i.e., total Cys and CysGly). We also observed a pronounced immune-inflammatory response at the post-trek sampling point, with a marked increase in urinary neopterin (a well-known marker of cellular immune system activation), the simultaneous upregulation of pro-inflammatory prostanoid levels (e.g., TXB2, PGE2, and 15-deoxy-delta12,14-PGJ2) and downregulation of omega-3 PUFAs and anti-inflammatory DiHETEs. These results clearly suggest an acute OxInflammation outbreak in response to the hypoxic trek, where muscle damage may have led to increased circulating PUFAs and ROS-mediated peroxidation [47].
The overproduction of ROS represents a well-established response to exercise [48,49,50]. High-altitude exercise induces oxidative stress and muscle fatigue to a greater extent since hypoxia increases ROS production and decreases antioxidant capacity [51,52,53]. Humans show complex multiple protective systems to maintain the redox homeostasis, starting with transitory effects that are highly regulated and modulated within minutes to longer lasting ones (over periods of days to years) [54]. Since redox signaling is required for numerous physiological processes, a disruption in redox homeostasis can regulate detrimental signaling pathways and produce harmful effects on several substrates [55].
Among lipids, PUFAs are majorly affected by free radical peroxidation, thus generating isoprostanes as principal end-products. Isoprostanes, such as 15-F2t-IsoP and 15-E2t-IsoP, have been found to amplify the vasoconstriction induced by angiotensin II (Ang-II) and endothelin-1 (ET-1) in hypoxic conditions [56]. The latter are strictly related to vascular xanthine oxidoreductase activity, which underlies hypoxia-induced oxidative damage combined with a reduction in mitochondrial redox potential [57], an increase in catecholamine production [58], and the activation of phospholipase A2.
ET-1 also induces inflammatory processes in the vascular wall and to promote the expression of proinflammatory cytokines [59], which in turn activates the production of prostaglandins through cyclooxygenases (COX) enzymes. Prostaglandins are pro-inflammatory and vasodilator immuno-mediators originating from arachidonic acid, whose plasma concentrations increase in response to high altitudes [60]. The release of COX-metabolites seems to be a key factor contributing to mountain sickness symptoms [61]. More broadly, hypoxia induces a substantial increase in the plasma concentration of most PUFA-derived eicosanoids, also produced from cytochrome P450 (CYP450) and lipoxygenase (LOX) enzymes [62]. Among LOX-metabolites, SPMs promote the resolution of inflammation thus enhancing the overall host response [63]. Nevertheless, whether the combination of high-altitude and exercise affects the resolution of inflammation or the release and activity of SPMs is still not fully clear, thus representing an interesting topic for future investigations.

5. Conclusions

Current physiological methods and molecular biological tools are improving and extending altitude physiology, allowing accurate measurements of the variables of interest and the responsible mechanisms [64]. Omics approaches are entering into the field of high-altitude medicine, since a comprehensive understanding of the biochemical response to hypoxia can define novel strategies for dealing with hypoxia-susceptible biomarkers in pathophysiology [65].
The wide set of potential biomarkers highlighted by this proof of concept entices for the design of case-control, hypothesis-testing studies to be proposed for enriching the theoretical and applicative insights in environmental and exercise physiology. Individual variability in hypoxia responses is growing interest for 5P medicine since oxygen deficiency is a key factor in many pathological processes. Therefore, besides the biomarkers suggested in the literature—such as hypoxia-inducible factor (HIF)-1, heat-shock protein 70 (HSP70), and nitric oxide (NO) [66]—oxylipins (as the ones targeted by this study) can be used to investigate the individual reactions to hypoxia.

Author Contributions

Conceptualization, D.B. (Danilo Bondi) and V.V.; Methodology, S.M.-S., D.B. (Denise Biagini), D.B. (Danilo Bondi), T.P., F.D.F. and V.V.; Formal analysis, S.M.-S., D.B. (Denise Biagini) and D.B. (Danilo Bondi); Investigation, S.M.-S., D.B. (Denise Biagini), D.B. (Danilo Bondi), T.P., A.V., T.L., F.D.F. and V.V.; Resources, S.M-.S., D.B. (Denise Biagini), D.B. (Danilo Bondi), T.P., A.V., T.L., F.D.F. and V.V.; Writing—original draft preparation, S.M.-S., D.B. (Denise Biagini) and D.B. (Danilo Bondi); Writing—review and editing, T.P., F.D.F. and V.V.; Visualization, S.M.-S., D.B. (Denise Biagini) and D.B. (Danilo Bondi); Supervision, T.P., F.D.F. and V.V.; Project administration, V.V.; Funding acquisition, V.V. and F.D.F. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

The study was conducted in accordance with the Declaration of Helsinki, and approved by the Ethical Review Board of the Nepal Health Research Council (NHRC, ref. no. 458) for studies involving humans.

Informed Consent Statement

Informed consent was obtained from all subjects involved in the study.

Data Availability Statement

Data is contained within the article.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. West, J.B. Early History of High-Altitude Physiology. Ann. N. Y. Acad. Sci. 2016, 1365, 33–42. [Google Scholar] [CrossRef] [PubMed]
  2. Moore, L.G. Measuring High-Altitude Adaptation. J. Appl. Physiol. 2017, 123, 1371–1385. [Google Scholar] [CrossRef] [PubMed]
  3. Magliulo, L.; Bondi, D.; Pietrangelo, T.; Fulle, S.; Piccinelli, R.; Jandova, T.; di Blasio, G.; Taraborrelli, M.; Verratti, V. Serum Ferritin and Vitamin D Evaluation in Response to High Altitude Comparing Italians Trekkers vs. Nepalese Porters. Eur. J. Sport Sci. 2020, 21, 994–1002. [Google Scholar] [CrossRef] [PubMed]
  4. Verratti, V.; Falone, S.; Doria, C.; Pietrangelo, T.; di Giulio, C. Kilimanjaro Abruzzo Expedition: Effects of High-Altitude Trekking on Anthropometric, Cardiovascular and Blood Biochemical Parameters. Sport Sci. Health 2015, 11, 271–278. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  5. Pham, K.; Parikh, K.; Heinrich, E.C. Hypoxia and Inflammation: Insights from High-Altitude Physiology. Front. Physiol. 2021, 12, 712. [Google Scholar] [CrossRef]
  6. Samanta, D.; Semenza, G.L. Maintenance of Redox Homeostasis by Hypoxia-Inducible Factors. Redox Biol. 2017, 13, 331–335. [Google Scholar] [CrossRef]
  7. Mrakic-Sposta, S.; Gussoni, M.; Dellanoce, C.; Marzorati, M.; Montorsi, M.; Rasica, L.; Pratali, L.; D’Angelo, G.; Martinelli, M.; Bastiani, L.; et al. Effects of Acute and Sub-Acute Hypobaric Hypoxia on Oxidative Stress: A Field Study in the Alps. Eur. J. Appl. Physiol. 2021, 121, 297–306. [Google Scholar] [CrossRef]
  8. Strapazzon, G.; Malacrida, S.; Vezzoli, A.; Dal Cappello, T.; Falla, M.; Lochner, P.; Moretti, S.; Procter, E.; Brugger, H.; Mrakic-Sposta, S. Oxidative Stress Response to Acute Hypobaric Hypoxia and Its Association with Indirect Measurement of Increased Intracranial Pressure: A Field Study. Sci. Rep. 2016, 6, 32426. [Google Scholar] [CrossRef]
  9. Pooja Sharma, V.; Sharma, M.; Varshney, R.; Kumar, B.; Sethy, N.K. Association Between 17β-Estradiol Receptors and Nitric Oxide Signaling Augments High-Altitude Adaptation of Ladakhi Highlanders. High Alt. Med. Biol. 2021, 22, 174–183. [Google Scholar] [CrossRef]
  10. Malacrida, S.; Giannella, A.; Ceolotto, G.; Reggiani, C.; Vezzoli, A.; Mrakic-Sposta, S.; Moretti, S.; Turner, R.; Falla, M.; Brugger, H.; et al. Transcription Factors Regulation in Human Peripheral White Blood Cells during Hypobaric Hypoxia Exposure: An in-Vivo Experimental Study. Sci. Rep. 2019, 9, 9901. [Google Scholar] [CrossRef] [Green Version]
  11. Valacchi, G.; Virgili, F.; Cervellati, C.; Pecorelli, A. OxInflammation: From Subclinical Condition to Pathological Biomarker. Front. Physiol. 2018, 9, 858. [Google Scholar] [CrossRef] [Green Version]
  12. Stables, M.J.; Gilroy, D.W. Old and New Generation Lipid Mediators in Acute Inflammation and Resolution. Prog. Lipid Res. 2011, 50, 35–51. [Google Scholar] [CrossRef] [PubMed]
  13. Curtis-Prior, P. The Eicosanoids; John Wiley & Sons, Ltd.: London, UK, 2004. [Google Scholar]
  14. Serhan, C.N. Pro-Resolving Lipid Mediators Are Leads for Resolution Physiology. Nature 2014, 510, 92–101. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  15. Levy, B.D.; Clish, C.B.; Schmidt, B.; Gronert, K.; Serhan, C.N. Lipid Mediator Class Switching during Acute Inflammation: Signals in Resolution. Nat. Immunol. 2001, 2, 612–619. [Google Scholar] [CrossRef]
  16. Galano, J.-M.; Lee, Y.Y.; Oger, C.; Vigor, C.; Vercauteren, J.; Durand, T.; Giera, M.; Lee, J.C.-Y. Isoprostanes, Neuroprostanes and Phytoprostanes: An Overview of 25 Years of Research in Chemistry and Biology. Prog. Lipid Res. 2017, 68, 83–108. [Google Scholar] [CrossRef]
  17. Jefferson, J.A.; Simoni, J.; Escudero, E.; Hurtado, M.E.; Swenson, E.R.; Wesson, D.E.; Schreiner, G.F.; Schoene, R.B.; Johnson, R.J.; Hurtado, A. Increased Oxidative Stress Following Acute and Chronic High Altitude Exposure. High Alt. Med. Biol. 2004, 5, 61–69. [Google Scholar] [CrossRef]
  18. Baillie, J.K.; Bates, M.G.D.; Thompson, A.A.R.; Waring, W.S.; Partridge, R.W.; Schnopp, M.F.; Simpson, A.; Gulliver-Sloan, F.; Maxwell, S.R.J.; Webb, D.J. Endogenous Urate Production Augments Plasma Antioxidant Capacity in Healthy Lowland Subjects Exposed to High Altitude. Chest 2007, 131, 1473–1478. [Google Scholar] [CrossRef] [PubMed]
  19. Verratti, V.; Ferrante, C.; Soranna, D.; Zambon, A.; Bhandari, S.; Orlando, G.; Brunetti, L.; Parati, G. Effect of High-Altitude Trekking on Blood Pressure and on Asymmetric Dimethylarginine and Isoprostane Production: Results from a Mount Ararat Expedition. J. Clin. Hypertens. 2020, 22, 1494–1503. [Google Scholar] [CrossRef] [PubMed]
  20. García-Flores, L.A.; Medina, S.; Cejuela, R.; Martínez-Sanz, J.M.; Oger, C.; Galano, J.M.; Durand, T.; Casas-Pina, T.; Martínez-Hernández, P.; Ferreres, F.; et al. Assessment of Oxidative Stress Biomarkers—Neuroprostanes and Dihomo-Isoprostanes—In the Urine of Elite Triathletes after Two Weeks of Moderate-Altitude Training. Free Radic. Res. 2016, 50, 485–494. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  21. Metherel, A.H.; Hogg, R.C.; Buzikievich, L.M.; Stark, K.D. Butylated Hydroxytoluene Can Protect Polyunsaturated Fatty Acids in Dried Blood Spots from Degradation for up to 8 Weeks at Room Temperature. Lipids Health Dis. 2013, 12, 1–10. [Google Scholar] [CrossRef] [Green Version]
  22. Bondi, D.; Aloisi, A.M.; Pietrangelo, T.; Piccinelli, R.; le Donne, C.; Jandova, T.; Pieretti, S.; Taraborrelli, M.; Santangelo, C.; Lattanzi, B.; et al. Feeding Your Himalayan Expedition: Nutritional Signatures and Body Composition Adaptations of Trekkers and Porters. Nutrients 2021, 13, 460. [Google Scholar] [CrossRef] [PubMed]
  23. Mrakic-Sposta, S.; Gussoni, M.; Montorsi, M.; Porcelli, S.; Vezzoli, A. A Quantitative Method to Monitor Reactive Oxygen Species Production by Electron Paramagnetic Resonance in Physiological and Pathological Conditions. Oxid. Med. Cell. Longev. 2014, 2014, 306179. [Google Scholar] [CrossRef] [Green Version]
  24. Kozik, V.; Jarzembek, K.; Jedrzejowska, A.; Bak, A.; Polak, J.; Bartoszek, M.; Pytlakowska, K. Investigation of Antioxidant Activity of Pomegranate Juices by Means of Electron Paramagnetic Resonance and UV-Vis Spectroscopy. J. AOAC Int. 2015, 98, 866–870. [Google Scholar] [CrossRef] [PubMed]
  25. Zang, S.; Tian, S.; Jiang, J.; Han, D.; Yu, X.; Wang, K.; Li, D.; Lu, D.; Yu, A.; Zhang, Z. Determination of Antioxidant Capacity of Diverse Fruits by Electron Spin Resonance (ESR) and UV-Vis Spectrometries. Food Chem. 2017, 221, 1221–1225. [Google Scholar] [CrossRef]
  26. Mrakic-Sposta, S.; Vezzoli, A.; Rizzato, A.; della Noce, C.; Malacrida, S.; Montorsi, M.; Paganini, M.; Cancellara, P.; Bosco, G. Oxidative Stress Assessment in Breath-Hold Diving. Eur. J. Appl. Physiol. 2019, 119, 2449–2456. [Google Scholar] [CrossRef] [PubMed]
  27. Mrakic-Sposta, S.; Vezzoli, A.; Maderna, L.; Gregorini, F.; Montorsi, M.; Moretti, S.; Greco, F.; Cova, E.; Gussoni, M. R(+)-Thioctic Acid Effects on Oxidative Stress and Peripheral Neuropathy in Type II Diabetic Patients: Preliminary Results by Electron Paramagnetic Resonance and Electroneurography. Oxid. Med. Cell. Longev. 2018, 2018, 1767265. [Google Scholar] [CrossRef] [PubMed]
  28. Dellanoce, C.; Cozzi, L.; Zuddas, S.; Pratali, L.; Accinni, R. Determination of Different Forms of Aminothiols in Red Blood Cells without Washing Erythrocytes. Biomed. Chromatogr. 2014, 28, 327–331. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  29. Vezzoli, A.; Dellanoce, C.; Mrakic-Sposta, S.; Montorsi, M.; Moretti, S.; Tonini, A.; Pratali, L.; Accinni, R. Oxidative Stress Assessment in Response to Ultraendurance Exercise: Thiols Redox Status and ROS Production According to Duration of a Competitive Race. Oxid. Med. Cell. Longev. 2016, 2016, 6439037. [Google Scholar] [CrossRef] [Green Version]
  30. Green, L.C.; Wagner, D.A.; Glogowski, J.; Skipper, P.L.; Wishnok, J.S.; Tannenbaum, S.R. Analysis of Nitrate, Nitrite, and [15N]Nitrate in Biological Fluids. Anal. Biochem. 1982, 126, 131–138. [Google Scholar] [CrossRef]
  31. Ghimenti, S.; Lomonaco, T.; Bellagambi, F.G.; Biagini, D.; Salvo, P.; Trivella, M.G.; Scali, M.C.; Barletta, V.; Marzilli, M.; di Francesco, F.; et al. Salivary Lactate and 8-Isoprostaglandin F2α as Potential Non-Invasive Biomarkers for Monitoring Heart Failure: A Pilot Study. Sci. Rep. 2020, 10, 7441. [Google Scholar] [CrossRef]
  32. Biagini, D.; Antoni, S.; Lomonaco, T.; Ghimenti, S.; Salvo, P.; Bellagambi, F.G.; Scaramuzzo, R.T.; Ciantelli, M.; Cuttano, A.; Fuoco, R.; et al. Micro-Extraction by Packed Sorbent Combined with UHPLC-ESI-MS/MS for the Determination of Prostanoids and Isoprostanoids in Dried Blood Spots. Talanta 2020, 206, 120236. [Google Scholar] [CrossRef] [PubMed]
  33. Biagini, D.; Franzini, M.; Oliveri, P.; Lomonaco, T.; Ghimenti, S.; Bonini, A.; Vivaldi, F.; Macera, L.; Balas, L.; Durand, T.; et al. MS-based targeted profiling of oxylipins in COVID-19: A new insight into inflammation regulation. Free Radic. Biol. Med. 2022, 180, 236–243. [Google Scholar] [CrossRef] [PubMed]
  34. Jollife, I.T.; Cadima, J. Principal Component Analysis: A Review and Recent Developments. Philos. Trans. R. Soc. A Math. Phys. Eng. Sci. 2016, 374, 20150202. [Google Scholar] [CrossRef]
  35. Xia, J.; Wishart, D.S. Metabolomic Data Processing, Analysis, and Interpretation Using MetaboAnalyst. Curr. Protoc. Bioinform. 2011, 34, 10–14. [Google Scholar] [CrossRef]
  36. Chong, J.; Wishart, D.S.; Xia, J. Using MetaboAnalyst 4.0 for Comprehensive and Integrative Metabolomics Data Analysis. Curr. Protoc. Bioinform. 2019, 68, e86. [Google Scholar] [CrossRef]
  37. Oliveri, P.; Malegori, C.; Simonetti, R.; Casale, M. The Impact of Signal Pre-Processing on the Final Interpretation of Analytical Outcomes—A Tutorial. Anal. Chim. Acta 2019, 1058, 9–17. [Google Scholar] [CrossRef] [PubMed]
  38. Tafuri, A.; Bondi, D.; Princiotta, A.; Pietrangelo, T.; Yadav, P.; Altieri, V.M.; Cerruto, M.A.; Pelliccione, F.; Antonelli, A.; Verratti, V. Effects of physical activity at high altitude on hormonal profiles in foreign trekkers and indigenous nepalese porters. In Best Practice in Health Care; Springer: Cham, Germany, 2021; pp. 111–119. [Google Scholar] [CrossRef]
  39. Prete, G.; Bondi, D.; Verratti, V.; Aloisi, A.M.; Rai, P.; Tommasi, L. Universality vs experience: A cross-cultural pilot study on the consonance effect in music at different altitudes. PeerJ 2020, 8, e9344. [Google Scholar] [CrossRef]
  40. Debevec, T.; Millet, G.P.; Pialoux, V. Hypoxia-Induced Oxidative Stress Modulation with Physical Activity. Front. Physiol. 2017, 8, 84. [Google Scholar] [CrossRef] [Green Version]
  41. Quindry, J.; Dumke, C.; Slivka, D.; Ruby, B. Impact of Extreme Exercise at High Altitude on Oxidative Stress in Humans. J. Physiol. 2016, 594, 5093–5104. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  42. Chicco, A.J.; Le, C.H.; Gnaiger, E.; Dreyer, H.C.; Muyskens, J.B.; D’Alessandro, A.; Nemkov, T.; Hocker, A.D.; Prenni, J.E.; Wolfe, L.M.; et al. Adaptive Remodeling of Skeletal Muscle Energy Metabolism in High-Altitude Hypoxia: Lessons from Altitude Omics. J. Biol. Chem. 2018, 293, 6659–6671. [Google Scholar] [CrossRef] [Green Version]
  43. O’Brien, K.A.; Simonson, T.S.; Murray, A.J. Metabolic Adaptation to High Altitude. Curr. Opin. Endocr. Metab. Res. 2020, 11, 33–41. [Google Scholar] [CrossRef]
  44. Howald, H.; Hoppeler, H. Performing at Extreme Altitude: Muscle Cellular and Subcellular Adaptations. Eur. J. Appl. Physiol. 2003, 90, 360–364. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  45. Bai, G.; Gao, Y.; Liu, S.; Shui, S.; Liu, G. PH-Dependent Rearrangement Determines the Iron-Activation and Antitumor Activity of Artemisinins. Free Radic. Biol. Med. 2021, 163, 234–242. [Google Scholar] [CrossRef] [PubMed]
  46. Rasica, L.; Porcelli, S.; Limper, U.; Mrakic-Sposta, S.; Mazzolari, R.; Gelmini, F.; Beretta, G.; Marzorati, M. Beet on Alps: Time-Course Changes of Plasma Nitrate and Nitrite Concentrations during Acclimatization to High-Altitude. Nitric Oxide Biol. Chem. 2021, 107, 66–72. [Google Scholar] [CrossRef] [PubMed]
  47. Hulbert, A.J. On the Importance of Fatty Acid Composition of Membranes for Aging. J. Theor. Biol. 2005, 234, 277–288. [Google Scholar] [CrossRef]
  48. Miller, L.E.; Mcginnis, G.R.; Kliszczewicz, B.; Slivka, D.; Hailes, W.; Miller, L.E.; Mcginnis, G.R.; Kliszczewicz, B.; Slivka, D.; Hailes, W.; et al. Blood Oxidative-Stress Markers during a High-Altitude Trek. Int. J. Sport Nutr. Exerc. Metab. 2013, 23, 65–72. [Google Scholar] [CrossRef]
  49. Biagini, D.; Lomonaco, T.; Ghimenti, S.; Fusi, J.; Cerri, E.; de Angelis, F.; Bellagambi, F.G.; Oger, C.; Galano, J.M.; Bramanti, E.; et al. Saliva as a Non-Invasive Tool for Monitoring Oxidative Stress in Swimmers Athletes Performing a VO2max Cycle Ergometer Test. Talanta 2020, 216, 120979. [Google Scholar] [CrossRef]
  50. He, F.; Li, J.; Liu, Z.; Chuang, C.C.; Yang, W.; Zuo, L. Redox Mechanism of Reactive Oxygen Species in Exercise. Front. Physiol. 2016, 7, 486. [Google Scholar] [CrossRef] [Green Version]
  51. Bailey, D.M.; Davies, B.; Young, I.S. Intermittent Hypoxic Training: Implications for Lipid Peroxidation Induced by Acute Normoxic Exercise in Active Men. Clin. Sci. 2001, 101, 465–475. [Google Scholar] [CrossRef]
  52. Tymko, M.M.; Tremblay, J.C.; Bailey, D.M.; Green, D.J.; Ainslie, P.N. The Impact of Hypoxaemia on Vascular Function in Lowlanders and High Altitude Indigenous Populations. J. Physiol. 2019, 597, 5759–5776. [Google Scholar] [CrossRef]
  53. Sinha, S.; Ray, U.S.; Saha, M.; Singh, S.N.; Tomar, O.S. Antioxidant and Redox Status after Maximal Aerobic Exercise at High Altitude in Acclimatized Lowlanders and Native Highlanders. Eur. J. Appl. Physiol. 2009, 106, 807–814. [Google Scholar] [CrossRef] [PubMed]
  54. Pomatto, L.C.D.; Davies, K.J.A. Adaptive Homeostasis and the Free Radical Theory of Ageing. Free Radic. Biol. Med. 2018, 124, 420–430. [Google Scholar] [CrossRef] [PubMed]
  55. Schieber, M.; Chandel, N.S. ROS Function in Redox Signaling and Oxidative Stress. Curr. Biol. 2014, 24, R453–R462. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  56. Sametz, W.; Grobuschek, T.; Hammer-Kogler, S.; Juan, H.; Wintersteiger, R. Influence of Isoprostanes on Vasoconstrictor Effects of Noradrenaline and Angiotensin II. Eur. J. Pharmacol. 1999, 378, 47–55. [Google Scholar] [CrossRef]
  57. Kowaltowski, A.J.; Vercesi, A.E. Mitochondrial damage induced by conditions of oxidative stress. Free Radic. Biol. Med. 1998, 26, 463–471. [Google Scholar] [CrossRef]
  58. Mazzeo, R.S.; Child, A.; Butterfield, G.E.; Mawson, J.T.; Zamudio, S.; Moore, L.G. Catecholamine response during 12 days of high-altitude exposure (4300 m) in women. J. Appl. Physiol. 1998, 84, 1151–1157. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  59. Yeager, M.E.; Belchenko, D.D.; Nguyen, C.M.; Colvin, K.L.; Ivy, D.D.; Stenmark, K.R. Endothelin-1, the Unfolded Protein Response, and Persistent Inflammation: Role of Pulmonary Artery Smooth Muscle Cells. Am. J. Respir. Cell Mol. Biol. 2012, 46, 14–22. [Google Scholar] [CrossRef]
  60. Richalet, J.-P.; Hornych, A.; Rathat, C.; Aumont, J.; Larmignat, P.; R6my, P. Plasma Prostaglandins, Leukotrienes and Thromboxane in Acute High Altitude Hypoxia. Respir. Physiol. 1991, 85, 205–215. [Google Scholar] [CrossRef]
  61. Benedetti, F.; Durando, J.; Vighetti, S. Nocebo and Placebo Modulation of Hypobaric Hypoxia Headache Involves the Cyclooxygenase-Prostaglandins Pathway. Pain 2014, 155, 921–928. [Google Scholar] [CrossRef] [PubMed]
  62. Voelkel, N.F.; Morganroth, M.; Feddersen, O.C. Potential Role of Arachidonic Acid Metabolites in Hypoxic Pulmonary Vasoconstriction. Chest 1985, 88, 245S–248S. [Google Scholar] [CrossRef] [Green Version]
  63. Chuong, P.; Wysoczynski, M.; Hellmann, J. Do Changes in Innate Immunity Underlie the Cardiovascular Benefits of Exercise? Front. Cardiovasc. Med. 2019, 6, 70. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  64. Wagner, P.D. Altitude Physiology then (1921) and now (2021): Meat on the bones. Physiol. Rev. 2022, 102, 323–332. [Google Scholar] [CrossRef] [PubMed]
  65. Koundal, S.; Gandhi, S.; Kaur, T.; Mazumder, A.; Khushu, S. “Omics” of High Altitude Biology: A Urinary Metabolomics Biomarker Study of Rats Under Hypobaric Hypoxia. OMICS A J. Integr. Biol. 2015, 19, 757–765. [Google Scholar] [CrossRef] [PubMed]
  66. Dzhalilova, D.; Makarova, O. Differences in tolerance to hypoxia: Physiological, biochemical, and molecular-biological characteristics. Biomedicines 2020, 8, 428. [Google Scholar] [CrossRef]
Antioxidants 11 00368 g001 550
Figure 1. Bar plots (mean ± SD) of redox results. (a) ROS production rate; (b) TAC; (c) NOx; (d) neopterin; (e–h) total concentration of aminothiols (Cys, cysteine; CysGly, cysteinylglycine; Hcty, homocysteine; GSH, glutathione) collected pre- and post- high-altitude trek (* p < 0.05, ** p < 0.01, *** p < 0.001, significantly different).
Figure 1. Bar plots (mean ± SD) of redox results. (a) ROS production rate; (b) TAC; (c) NOx; (d) neopterin; (e–h) total concentration of aminothiols (Cys, cysteine; CysGly, cysteinylglycine; Hcty, homocysteine; GSH, glutathione) collected pre- and post- high-altitude trek (* p < 0.05, ** p < 0.01, *** p < 0.001, significantly different).
Antioxidants 11 00368 g001
Antioxidants 11 00368 g002 550
Figure 2. (a) Score plot and (b) loading plot of PCA performed on the overall dataset. Red and green symbols represent trekkers pre- and post-high-altitude trek, respectively. Data were pre-processed (i.e., square root transformation and data autoscaling) prior to the multivariate analysis.
Figure 2. (a) Score plot and (b) loading plot of PCA performed on the overall dataset. Red and green symbols represent trekkers pre- and post-high-altitude trek, respectively. Data were pre-processed (i.e., square root transformation and data autoscaling) prior to the multivariate analysis.
Antioxidants 11 00368 g002
Table
Table 1. Statistical results.
Table 1. Statistical results.
Testp-ValueCohen’s d Unbiased95% CI
LowerUpper
15-F2t-IsoPWilcoxon0.035−2.041−4.046−0.746
TX-B2Student0.073−0.777−1.869−0.080
15-E2t-IsoPWilcoxon0.4380.300
PGE2Student0.043−0.927−2.110−0.032
14,15-DiHETEStudent0.0730.777−0.0811.868
11,12-DiHETEStudent0.0750.772−0.0851.860
LEU-B4Student0.0012.1920.8334.339
8,9-DiHETEStudent0.0830.744−0.1061.817
15-deoxy-delta12,14-PGJ2Student0.022−1.128−2.446−0.174
20-HETEStudent0.0430.9290.0332.113
13-HODEStudent0.1360.611−0.2131.611
15-HETEStudent0.4050.312
12-HETEStudent0.2260.475
5-HETEStudent0.5640.212
14,15-EETStudent0.0390.9530.0512.153
11,12-EETWilcoxon0.7100.205
8,9-EETStudent0.035−0.986−2.208−0.075
AdAStudent0.1220.639−0.1891.654
EPAStudent0.1150.656−0.1761.679
alpha-LAWilcoxon0.8440.219
DHAStudent0.0081.4860.4103.067
AAStudent0.6100.187
DPAStudent0.0610.826−0.0431.946
LAStudent0.0181.1880.2152.548
CreatinineStudent0.763−0.109
Neopterin/CreatinineStudent0.010−1.396−2.909−0.353
Uric acidStudent0.296−0.402
Uric acid/CreatinineWilcoxon0.6880.044
NOxStudent0.020−1.156−2.493−0.194
Cys STStudent<0 .0012.4580.9834.829
CysGly STStudent0.0021.9300.6813.863
Hcy STStudent0.0291.0390.1122.295
GSH STStudent<0.001−3.607−6.967−1.600
ROSStudent< 0.001−4.134−7.957−1.873
TACStudent<0.0012.9891.2735.812
Note: Italics represent those values that decreased from pre to post expedition (as also expressed by the positive sign of the effect size); grey-background rows represent the significant results (p < 0.05), and among them dark-grey rows represent the most consistent findings (absolute range of 95% C.I. of effect size over 0.4).
Table
Table 2. Oxylipin mean concentration levels measured pre- and post-high-altitude trek.
Table 2. Oxylipin mean concentration levels measured pre- and post-high-altitude trek.
Compound *Pre-Altitude TrekPost-Altitude Trek
MeanSDMeanSD
15-F2t-IsoP0.0240.0060.060.01
TX-B20.60.51.10.4
PGE20.050.030.110.07
14,15-DiHETE0.0080.0050.0040.001
11,12-DiHETE0.0080.0060.0036 × 10−4
LEU-B40.10.20.030.03
8,9-DiHETE0.0080.0040.0067 × 10−4
15-deoxy-Δ12,14-PGJ20.0060.0060.020.02
20-HETE0.030.020.0220.008
13-HODE206134
15-HETE0.30.20.40.2
12-HETE2020306
5-HETE0.30.20.270.06
14,15-EET0.0150.0060.0120.005
11,12-EET0.0040.0010.0030.002
8,9-EET0.020.020.0260.009
AdA4000300030001000
EPA500030002500900
alpha-LA20,00010,00016,0009000
DHA20,000700014,0005000
AA18,000900017,0004000
DPA4000300030001000
LA23,000300020,0003000
* All concentration levels are reported as ppb. Significant changes (p < 0.05) are reported in bold.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Mrakic-Sposta, S.; Biagini, D.; Bondi, D.; Pietrangelo, T.; Vezzoli, A.; Lomonaco, T.; Di Francesco, F.; Verratti, V. OxInflammation at High Altitudes: A Proof of Concept from the Himalayas. Antioxidants 2022, 11, 368. https://0-doi-org.brum.beds.ac.uk/10.3390/antiox11020368

AMA Style

Mrakic-Sposta S, Biagini D, Bondi D, Pietrangelo T, Vezzoli A, Lomonaco T, Di Francesco F, Verratti V. OxInflammation at High Altitudes: A Proof of Concept from the Himalayas. Antioxidants. 2022; 11(2):368. https://0-doi-org.brum.beds.ac.uk/10.3390/antiox11020368

Chicago/Turabian Style

Mrakic-Sposta, Simona, Denise Biagini, Danilo Bondi, Tiziana Pietrangelo, Alessandra Vezzoli, Tommaso Lomonaco, Fabio Di Francesco, and Vittore Verratti. 2022. "OxInflammation at High Altitudes: A Proof of Concept from the Himalayas" Antioxidants 11, no. 2: 368. https://0-doi-org.brum.beds.ac.uk/10.3390/antiox11020368

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop